Question 1

What is Lucid Capital Markets?

Accepted Answer

Lucid Capital Markets is a Entity.

Question 2

How often does Lucid Capital Markets appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 25 articles.

Question 3

When was Lucid Capital Markets first tracked by Ergen?

Accepted Answer

First tracked on Apr 14, 2026.

Question 4

When was Lucid Capital Markets last mentioned in news?

Accepted Answer

Last active on Jun 08, 2026.

Question 5

What is Lucid Capital Markets's current news sentiment?

Accepted Answer

Aggregate sentiment score: 3 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Lucid Capital Markets in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Lucid Capital Markets?

Accepted Answer

NRx Pharmaceuticals Prices Public Offering (Jun 02, 2026, 10 articles).

Question 8

How did the "NRx Pharmaceuticals Prices Public Offering" event impact Lucid Capital Markets?

Accepted Answer

Lucid Capital Markets, LLC is acting as a joint bookrunning manager for the public offering by NRx Pharmaceuticals, assisting in the sale of shares.

Question 9

How did the "FS KKR Capital Corp. $900M Notes Offering" event impact Lucid Capital Markets?

Accepted Answer

Lucid Capital Markets, LLC acted as a co-manager for the offering.

Question 10

How did the "Galera and Obsidian Therapeutics Merger" event impact Lucid Capital Markets?

Accepted Answer

Lucid Capital Markets provided a fairness opinion to Galera Therapeutics' Board of Directors.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.